REFRACTORY SARCOMA

Clinical trials for REFRACTORY SARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for young patients battling aggressive cancers

Disease control Recruiting now

This study is testing a new drug called PEEL-224 combined with two existing cancer drugs to see if it can help control aggressive sarcomas that have returned or stopped responding to standard treatments. It will involve about 63 adolescents and young adults (ages 12-49) with spec…

Matched conditions: REFRACTORY SARCOMA

Phase: PHASE1, PHASE2 • Sponsor: David S Shulman, MD • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

REFRACTORY SARCOMA

Get alerted when new REFRACTORY SARCOMA trials appear

New hope for young patients battling aggressive cancers